A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3663-3672

  Rowe, Alexander M ^a,c,d   Murray, Susan E ^a   Raué, Hans Peter ^b   Koguchi, Yoshinobu ^a   Slifka, Mark K ^a,b   Parker, David C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 7 RECEPTOR; NUCLEAR FACTOR KAPPA B INDUCING KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARENAVIRUS INFECTION; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME ANALYSIS; IMMUNE SYSTEM; KNOCKOUT MOUSE; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; WILD TYPE;

ANIMALS; ARENAVIRIDAE INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHIMERA; FEMALE; IMMUNOLOGIC MEMORY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, INTERLEUKIN-7;

EID: 84884483844     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301328     Document Type: Article

References (62)

1. Curtsinger, J. M., and M. F. Mescher. 2010. Inflammatory cytokines as a third signal for T cell activation. Curr. Opin. Immunol. 22:333-340.
2. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23:23-68.
3. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9:271-285.
4. So, T., H. Choi, and M. Croft. 2011. OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J. Immunol. 186:3547-3555.
5. Song, J., T. So, and M. Croft. 2008. Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival. J. Immunol. 180:7240-7248.
6. Murray, S. E., F. Polesso, A. M. Rowe, S. Basak, Y. Koguchi, K. G. Toren, A. Hoffmann, and D. C. Parker. 2011. NF-κB-inducing kinase plays an essential T cell-intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J. Clin. Invest. 121:4775-4786.
7. Beinke, S., and S. C. Ley. 2004. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382:393-409.
8. Sun, S. C. 2012. The noncanonical NF-κB pathway. Immunol. Rev. 246:125-140.
9. Xiao, G., E. W. Harhaj, and S. C. Sun. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7:401-409.
10. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krähn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499.
11. Ishimaru, N., H. Kishimoto, Y. Hayashi, and J. Sprent. 2006. Regulation of naive T cell function by the NF-kappaB2 pathway. Nat. Immunol. 7:763-772.
12. Basak, S., H. Kim, J. D. Kearns, V. Tergaonkar, E. O'Dea, S. L. Werner, C. A. Benedict, C. F. Ware, G. Ghosh, I. M. Verma, and A. Hoffmann. 2007. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 128:369-381.
13. Legarda-Addison, D., and A. T. Ting. 2007. Negative regulation of TCR signaling by NF-kappaB2/p100. J. Immunol. 178:7767-7778.
14. Giardino Torchia, M. L., D. B. Conze, D. Jankovic, and J. D. Ashwell. 2013. Balance between NF-κB p100 and p52 regulates T cell costimulation dependence. J. Immunol. 190:549-555.
15. Hauer, J., S. Püschner, P. Ramakrishnan, U. Simon, M. Bongers, C. Federle, and H. Engelmann. 2005. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. USA 102:2874-2879.
16. Rauert, H., A. Wicovsky, N. Müller, D. Siegmund, V. Spindler, J. Waschke, C. Kneitz, and H. Wajant. 2010. Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem. 285:7394-7404.
17. McPherson, A. J., L. M. Snell, T. W. Mak, and T. H. Watts. 2012. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J. Biol. Chem. 287:23010-23019.
18. Xiao, X., S. Balasubramanian, W. Liu, X. Chu, H. Wang, E. J. Taparowsky, Y. X. Fu, Y. Choi, M. C. Walsh, and X. C. Li. 2012. OX40 signaling favors the induction of T (H) 9 cells and airway inflammation. Nat. Immunol. 13:981-990.
19. Yin, L., L. Wu, H. Wesche, C. D. Arthur, J. M. White, D. V. Goeddel, and R. D. Schreiber. 2001. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291:2162-2165.
20. Akiyama, T., Y. Shimo, H. Yanai, J. Qin, D. Ohshima, Y. Maruyama, Y. Asaumi, J. Kitazawa, H. Takayanagi, J. M. Penninger, et al. 2008. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29:423-437.
21. Claudio, E., K. Brown, S. Park, H. Wang, and U. Siebenlist. 2002. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-965.
22. Hofmann, J., F. Mair, M. Greter, M. Schmidt-Supprian, and B. Becher. 2011. NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses. J. Exp. Med. 208:1917-1929.
23. Lind, E. F., C. L. Ahonen, A. Wasiuk, Y. Kosaka, B. Becher, K. A. Bennett, and R. J. Noelle. 2008. Dendritic cells require the NF-kappaB2 pathway for crosspresentation of soluble antigens. J. Immunol. 181:354-363.
24. Tamura, C., M. Nakazawa, M. Kasahara, C. Hotta, M. Yoshinari, F. Sato, and M. Minami. 2006. Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD25+CD4+ regulatory T cells. Autoimmunity 39:445-453.
25. Matsumoto, M., T. Yamada, S. K. Yoshinaga, T. Boone, T. Horan, S. Fujita, Y. Li, and T. Mitani. 2002. Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway. J. Immunol. 169:1151-1158.
26. Kajiura, F., S. Sun, T. Nomura, K. Izumi, T. Ueno, Y. Bando, N. Kuroda, H. Han, Y. Li, A. Matsushima, et al. 2004. NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 172:2067-2075.
27. Lakkis, F. G., A. Arakelov, B. T. Konieczny, and Y. Inoue. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686-688.
28. Yamada, T., T. Mitani, K. Yorita, D. Uchida, A. Matsushima, K. Iwamasa, S. Fujita, and M. Matsumoto. 2000. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J. Immunol. 165:804-812.
29. Karrer, U., A. Althage, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 2000. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect. Eur. J. Immunol. 30:2799-2807.
30. Aya, K., M. Alhawagri, A. Hagen-Stapleton, H. Kitaura, O. Kanagawa, and D. V. Novack. 2005. NF-(kappa) B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J. Clin. Invest. 115:1848-1854.
31. Jin, W., X. F. Zhou, J. Yu, X. Cheng, and S. C. Sun. 2009. Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. Blood 113:6603-6610.
32. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:390-400.
33. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
34. Homann, D., H. Lewicki, D. Brooks, J. Eberlein, V. Mallet-Designé, L. Teyton, and M. B. Oldstone. 2007. Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II. Virology 363:113-123.
35. Williams, M. A., E. V. Ravkov, and M. J. Bevan. 2008. Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity 28:533-545.
36. Joshi, N. S., and S. M. Kaech. 2008. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J. Immunol. 180:1309-1315.
37. Dong, H., N. A. Franklin, D. J. Roberts, H. Yagita, M. J. Glennie, and T. N. Bullock. 2012. CD27 stimulation promotes the frequency of IL-7 receptorexpressing memory precursors and prevents IL-12-mediated loss of CD8 (+) T cell memory in the absence of CD4 (+) T cell help. J. Immunol. 188:3829-3838.
38. Bullock, T. N., and H. Yagita. 2005. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J. Immunol. 174:710-717.
39. Hendriks, J., L. A. Gravestein, K. Tesselaar, R. A. van Lier, T. N. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-440.
40. Matter, M. S., C. Claus, and A. F. Ochsenbein. 2008. CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. Eur. J. Immunol. 38:1847-1856.
41. Takahashi, C., R. S. Mittler, and A. T. Vella. 1999. Cutting edge:4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162:5037-5040.
42. Mousavi, S. F., P. Soroosh, T. Takahashi, Y. Yoshikai, H. Shen, L. Lefrançois, J. Borst, K. Sugamura, and N. Ishii. 2008. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J. Immunol. 181:5990-6001.
43. Rowley, T. F., and A. Al-Shamkhani. 2004. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. J. Immunol. 172:6039-6046.
44. Tan, J. T., J. K. Whitmire, R. Ahmed, T. C. Pearson, and C. P. Larsen. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163:4859-4868.
45. Peperzak, V., Y. Xiao, E. A. Veraar, and J. Borst. 2010. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J. Clin. Invest. 120:168-178.
46. Pulle, G., M. Vidric, and T. H. Watts. 2006. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J. Immunol. 176:2739-2748.
47. Dawicki, W., E. M. Bertram, A. H. Sharpe, and T. H. Watts. 2004. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J. Immunol. 173:5944-5951.
48. Maxwell, J. R., A. Weinberg, R. A. Prell, and A. T. Vella. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107-112.
49. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M. F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11:699-708.
50. Evans, D. E., R. A. Prell, C. J. Thalhofer, A. A. Hurwitz, and A. D. Weinberg. 2001. Engagement of OX40 enhances antigen-specific CD4 (+) T cell mobilization/memory development and humoral immunity: comparison of aOX-40 with αCTLA-4. J. Immunol. 167:6804-6811.
51. Mendel, I., and E. M. Shevach. 2006. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology 117:196-204.
52. Snell, L. M., G. H. Lin, and T. H. Watts. 2012. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15. J. Immunol. 188:5915-5923.
53. Hendriks, J., Y. Xiao, J. W. Rossen, K. F. van der Sluijs, K. Sugamura, N. Ishii, and J. Borst. 2005. During viral infection of the respiratory tract, CD 27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 175:1665-1676.
54. Tucker, E., K. O'Donnell, M. Fuchsberger, A. A. Hilton, D. Metcalf, K. Greig, N. A. Sims, J. M. Quinn, W. S. Alexander, D. J. Hilton, et al. 2007. A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor." J. Immunol. 179:7514-7522.
55. Shih, V. F., R. Tsui, A. Caldwell, and A. Hoffmann. 2011. A single NFkB system for both canonical and non-canonical signaling. Cell Res. 21:86-102.
56. Thu, Y. M., and A. Richmond. 2010. NF-kB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev. 21:213-226.
57. Li, Y., C. E. Sedwick, J. Hu, and A. Altman. 2005. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation. J. Biol. Chem. 280:1217-1223.
58. Sánchez-Valdepeñas, C., A. G. Martín, P. Ramakrishnan, D. Wallach, and M. Fresno. 2006. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity. J. Immunol. 176:4666-4674.
59. Shui, J. W., A. Larange, G. Kim, J. L. Vela, S. Zahner, H. Cheroutre, and M. Kronenberg. 2012. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488:222-225.
60. Fagarasan, S., R. Shinkura, T. Kamata, F. Nogaki, K. Ikuta, K. Tashiro, and T. Honjo. 2000. Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J. Exp. Med. 191:1477-1486.
61. Karnell, J. L., and R. Ettinger. 2012. The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory. Front Immunol 3:2.
62. Yang, C. H., A. Murti, S. R. Pfeffer, M. Fan, Z. Du, and L. M. Pfeffer. 2008. The role of TRAF2 binding to the type I interferon receptor in alternative NF kappaB activation and antiviral response. J. Biol. Chem. 283:14309-14316.